MBX MBX Biosciences, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $2.8B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $136.0M | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $4.6M | $0 |
| 2025-Q2 | $45.3K | $0 |
| 2025-Q3 | $12.0M | $0 |
| 2025-Q4 | $537.8K | $0 |
| 2026-Q1 | $525.6K | $0 |
| 2026-Q2 | $0 | $2.7M |
| 2026-Q3 | $0 | $24.3K |
| 2026-Q4 | $0 | $288.4K |
Bought$153.7M25 buy days
Sold$3.0M6 sell days
Net insider flow+$150.7Mnet buying · 5 years
Latest trade2026-11-10Hoerter Steven L.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Sell | Hoerter Steven L. | CEO | 4,893 | $54.82 | $268.2K | 1 |
| 2026-11-04 | Sell | Azoulay Salomon | Other C-suite | 373 | $53.96 | $20.1K | 1 |
| 2026-08-04 | Sell | Azoulay Salomon | Other C-suite | 370 | $65.77 | $24.3K | 1 |
| 2026-05-08 | Sell | Azoulay Salomon | Other C-suite | 70,003 | $38.36 | $2.7M | 2 |
| 2026-05-06 | Sell | Hawryluk P. Kent | CEO | 607 | $29.54 | $17.9K | 1 |
| 2026-05-06 | Sell | Azoulay Salomon | Other C-suite | 231 | $29.54 | $6.8K | 1 |
| 2026-03-13 | Buy | Hawryluk P. Kent | CEO | 18,500 | $28.41 | $525.6K | 1 |
| 2025-10-20 | Buy | Hawryluk P. Kent | CEO | 20,000 | $13.64 | $272.8K | 1 |
| 2025-10-17 | Buy | Hoerter Steven L. | Director | 20,000 | $13.25 | $265.0K | 1 |
| 2025-09-26 | Buy | Heron Patrick J | Director | 666,666 | $18.00 | $12.0M | 1 |
| 2025-04-08 | Buy | Pescovitz Ora H. | Director | 7,693 | $5.89 | $45.3K | 1 |
| 2025-02-18 | Buy | GORDON CARL L | Director | 143,170 | $10.84 | $1.6M | 2 |
| 2025-02-18 | Buy | ORBIMED ADVISORS LLC | Director | 143,170 | $10.84 | $1.6M | 2 |
| 2025-02-14 | Buy | ORBIMED ADVISORS LLC | Director | 47,502 | $9.87 | $468.8K | 2 |
| 2025-02-14 | Buy | GORDON CARL L | Director | 47,502 | $9.87 | $468.8K | 2 |
| 2025-02-04 | Buy | Hawryluk P. Kent | CEO | 50,000 | $10.69 | $534.5K | 1 |
| 2024-09-16 | Buy | ORBIMED ADVISORS LLC | Director | 750,000 | $16.00 | $12.0M | 2 |
| 2024-09-16 | Buy | GORDON CARL L | Director | 750,000 | $16.00 | $12.0M | 2 |
| 2024-09-16 | Buy | Aynechi Tiba | Director | 750,000 | $16.00 | $12.0M | 1 |
| 2024-09-16 | Buy | Topper James N | 10% owner | 625,000 | $16.00 | $10.0M | 1 |
| 2024-09-16 | Buy | Heron Patrick J | Director | 625,000 | $16.00 | $10.0M | 1 |
| 2024-09-16 | Buy | BASKETT FOREST | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | Mathers Edward T | Director | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | Chang Carmen | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | Makhzoumi Mohamad | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | Florence Anthony A. Jr. | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | Walker Paul Edward | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | Yang Rick | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | SANDELL SCOTT D | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | New Enterprise Associates 17, L.P. | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
| 2024-09-16 | Buy | Behbahani Ali | 10% owner | 500,000 | $16.00 | $8.0M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Heron Patrick J | Director | $32.0M | $0 | 2025-09-26 |
| GORDON CARL L | Director | $14.0M | $0 | 2025-02-18 |
| ORBIMED ADVISORS LLC | Director | $14.0M | $0 | 2025-02-18 |
| Aynechi Tiba | Director | $12.0M | $0 | 2024-09-16 |
| BASKETT FOREST | 10% owner | $8.0M | $0 | 2024-09-16 |
| Behbahani Ali | 10% owner | $8.0M | $0 | 2024-09-16 |
| Chang Carmen | 10% owner | $8.0M | $0 | 2024-09-16 |
| Florence Anthony A. Jr. | 10% owner | $8.0M | $0 | 2024-09-16 |
| Makhzoumi Mohamad | 10% owner | $8.0M | $0 | 2024-09-16 |
| Mathers Edward T | Director | $8.0M | $0 | 2024-09-16 |
| New Enterprise Associates 17, L.P. | 10% owner | $8.0M | $0 | 2024-09-16 |
| SANDELL SCOTT D | 10% owner | $8.0M | $0 | 2024-09-16 |
| Walker Paul Edward | 10% owner | $8.0M | $0 | 2024-09-16 |
| Yang Rick | 10% owner | $8.0M | $0 | 2024-09-16 |
| Azoulay Salomon | Other C-suite | $0 | $2.7M | 2026-11-04 |
| Hawryluk P. Kent | CEO | $1.3M | $17.9K | 2026-05-06 |
| Hoerter Steven L. | CEO | $265.0K | $268.2K | 2026-11-10 |
| Pescovitz Ora H. | Director | $45.3K | $0 | 2025-04-08 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-09-26 → 2025-10-20 | 3 | $12.5M | 65 | +78.8% (+71.9% raw) | +132.8% (+140.8% raw) | +90.3% (+103.3% raw) | closed |
| 2025-02-04 → 2025-02-18 | 3 | $4.6M | 69 | -22.9% (-32.5% raw) | +14.7% (+4.8% raw) | +20.6% (+21.0% raw) | closed |
| 2024-09-16 | 14 | $136.0M | 57 | +4.1% (+7.7% raw) | -15.0% (-7.4% raw) | -64.3% (-63.3% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.